The receptor mediated activation of phospholipase A2 by appropriate ligands results in the synthesis and release of eicosanoids, a class of potent bioregulatory molecules. Madin-Darby canine kidney cells (MDCK) are polarized epithelial cells, with structurally and functionally distinct plasma membrane domains separated by tight junctions. Using MDCK cells grown in dual sided chambers, we show in this report, that a) the receptor mediated release of prostaglandins and arachidonate into the extracellular medium is predominantly unidirectional, b) the direction of release is agonist specific, and c) the magnitude of the response due to a given agonist is cell-domain specific. These characteristics, if operative in vivo, would contribute towards the optimal function of trans-cellular metabolism of eicosanoids already demonstrated.
The receptor mediated activation of phospholipase A2 by appropriate ligands results in the synthesis and release of eicosanoids, a class of potent bioregulatory molecules. Madin-Darby canine kidney cells (MDCK) are polarized epithelial cells, with structurally and functionally distinct plasma membrane domains separated by tight junctions. Using MDCK cells grown in dual sided chambers, we show in this report, that a) the receptor mediated release of prostaglandins and arachidonate into the extracellular medium is predominantly unidirectional, b) the direction of release is agonist specific, and c) the magnitude of the response due to a given agonist is cell-domain specific. These characteristics, if operative in vivo, would contribute towards the optimal function of trans-cellular metabolism of eicosanoids already demonstrated.
Introduction:
Madin-Darby canine epithelial cells have been extensively used to study epithelial polarity and membrane sorting processes in mammalian cells growing in specialized culture environments. When appropriately grown in cell culture systems, these cells exhibit properties characteristic of polarized epithelial cells in culture. They grow forming a tightly sealed monolayer and show the expected structural and functional polarity (l-6). There is considerable evidence to show that MDCK cells sort out newly synthesized apical and basolateral plasma membrane proteins intracellularly and then transcytose them to correct plasma membrane domains (7-12). The resulting asymmetrical distribution of functional molecules in the membrane will dictate the nature of polarized behavior exhibited by the cells (13) (14) (15) .
Eicosanoids are physiological response modulators which act in both autocrine as well as in paracrine fashions on target cells (16, 17 ). An eicosanoid synthesized in one cell has been shown to be the substrate for metabolic transformations by another cell type in more than one biological system (N-24). Such transcellular metabolic routes are conceivably most effective if the secretion is vectorially focussed in a polarized manner from one cell to another. MDCK cells synthesize and secrete relatively large quantities of prostaglandins (PGs), and have been used to study the roles played by PGs in various cellular functions (25) (26) (27) . In this report we have used MDCK cells to study the nakre and consequences of epithelial polarity when the cells are stimulated to produce and release arachidonate (AA) and its PG metabolites.
Materials and methods: [5,6,8,9,\1412,14,15-3 H] AA with specific activity 23OWmmol and uniformly labeled [ C!] sucrose with specific activity of 540 mCWmmol were purchased from Amersham. Bradykinin and PG standards were from Sigma. Ionomycin was purchased from Calbiochem; ATP-y-S was from Boehringer Mannheim, and 24 mm Transwell plates with (0.4 micron pore size) polycarbonate filters were from Costar, Cambridge, MA.
Cell Culture:
MDCK cells (ATCC CCL.34) were grown in 75 cm2 tissue culture flasks in DMEM supplemented with 10% fetal calf serum. After reaching confluency, the cells were prepared by trypsinizing and plating them at low density on to the polycarbonate filter of the transwell plates. The number of cells plated per well were adjusted so that the monolayer would have to divide at least 3-4 times to reach saturation density. The media was changed to contain 0.5% serum in both chambers of the transwel124 hours before the experiments were begun.
Measurement
of AA and PGs:
3[H] AA and its released metabolites were extracted from the medium and analyzed as previously reported (28). When PGs in the medium were not quantitated, AA release was taken to be the total cpm released into the medium. This assumption is justified, since the contribution of cpm from the PG products under these conditions is negligible when compared to the cpm contained in AA. (Fig. 6) .
Results:
To verify that the dual-chambered transwell model is an adequate experimental system to detect and quantitate vectorial release of metabolites, the following experiments were performed.
Cells were grown into a confluent monolayer on the filter as described in Materials and Methods.
The tightness of the monolayer to passive diffusion of sucrose or AA was tested as described in the legends of Fig. 1A and lB, respectively. The basolateral (bottom) chamber was sampled at the indicated times. Results are expressed as the percent of the total dpm appearing in the basolateral chamber. From the data presented in Figures 1A and 1B the following conclusions may be drawn: a) the rate of diffusion of sucrose or AA through a confluent cell monolayer of MDCK cells in a transwell is a slow process compared to the rates observed for their diffusion across the filter alone, b) in the presence of a MDCK cell monolayer, there is negligible mixing of the contents of the apical and basolateral wells up to 30 minutes of incubation.
TIME (min)
Additional experiments using a variety of agonists indicated that the time course of release of AA was linear when the stimulation was restricted to five minute periods (data not given). The basal release without added agonists was reproducible, averaging close to the cpms given in the legend of Fig. 2 .
In the experiments described below, unless otherwise stated, the release is expressed as fold increase over the basal, since the basal release was comparable to that given in the legend of Bradykinin is a well documented peptide agonist for the stimulation of phospholipase A2 and PG release (29, 30) . Using bradykinin as an activator of phospholipase A2, several novel features which characterize the stimulated release of AA are evident in the experiments described, due to the epithelial polarity of the MDCK cells. Fig. 2 shows the effect of 5 min. of stimulation of the cells, with bradykinin added either from the apical or the basolateral side of the transwell.
Note that not only is the extent of stimulation five fold higher when the peptide is added from the apical well, almost all of the AA released is predominantly secreted into the basolateral compartment of the transwell. Thus, in cells showing epithelial polarity, the agonist receptor interaction may be side-specific (apical vs basolateral), and the secretion of the interaction product (AA in this case) is vectorially directed. Interestingly, the direction of secretion is opposite to that of the side to which the agonist was added.
log [BRADYKININ]
-6 ED50 48 nM 38 nM (Fig. 2) to be maximal when bradykinin was added from the apical side of the cell, the dose response for this agonist was measured only with the agonist added to the apical side of the cell. The maximal and minimal responses were obtained between concentrations ranges of 10q6 to lo-' M bradykinin. Throughout this concentration range, the release was found to be vectorial with about two fold more AA released into the basolateral well, at each concentration of the agonist used. However, the ED50 of bradykinin for AA release on both sides were approximately equal, 38 nM for apical vs 48 nM for basolateral.
4.6-
log [ATP-y-S] ATP has been shown to stimulate phospholipase activity and PG production by interacting with the purinergic receptors of the target cells (31) . The experiments described were repeated using ATP-y-S as the agonist. Similar to bradykinin, the ATP-y-S added from the basolateral side failed to release appreciable quantities of AA (data not given). The dose response of ATP-y-S for release of AA to both sides of the cells is shown in Fig. 4 . A seven-fold increase in release of AA may be observed in this experiment at the maximal dose of the agonist used. The secretion of AA is vector-al, directed primarily from the basolateral side of the cells. The ED50 for ATP-y-S for the release of AA to both sides were of similar magnitude, 28 pM for basolateral vs 50 pM for the apical side. Fig. 5a shows the release when the agonist was added from the apical well. Fig. 5b represents addition of ionomycin from the basolateral well. After five mins of incubation with the cells, aliquots of media were collected from the apical (filled circle) and basolateral wells (open circle) and counted.
In Fig. 5 , dose-response data is given for ionomycin, employing the same protocol described for bradykinin and ATP-y-S. The activation of phospholipase A2 by ionomycin is mediated by Ca++ ions -a different mechanism (32) from that of the receptor mediated activation of the enzyme, described for bradykinin and ATP-y-S . Appreciable release of AA was observed with ionomycin, when added either from apical side (Fig. 5a ) or from basolateral side (Fig. 5b) . However, the release was significantly vectorial, but only when the agonist was added from the basolateral side. In this case about 10 fold more AA was released into the basolateral side compared to the apical side, at the maximal concentration of the agonist used (Fig. 5b) . Regardless of the side of addition, the ED50 of ionomycin for AA release was of the same order of magnitude (Fig 5a and Fig 5b) , for both apical and basolateral compartments of the transwell.
In experiments described below, the media was collected after addition of a variety of stimulating agents and processed by TLC (28) to quantify the AA and eicosanoids present in the apical and basolateral compartments of the cells. Results shown in lanes 5-8 demonstrate that trypsin is effective in AA release and PG production when added from either side of the transwell. However, clear polarity of secretion is apparent with most of the PG products directed to the apical side of the transwell (lanes 5,7,8, and 11). Lanes 9-12 show that the synthesis of PGs is dependent on the concentration of the agonist, but the direction of polarity is independent of the dose of the agonist. MDCK cells have been extensively used in in vitro studies to understand the nature of polarity in epithelial cells (l-6). To our knowledge this is the first report investigating polarized secretion of AA and its eicosanoid products in stimulated epithelial cells. We have used agonists belonging to three different classes -based on their known mechanisms of stimulation -for eicosanoid production and release by the cells. These are: a) stimulation of cells by peptide agonists (bradykinin, thrombin, trypsin); b) stimulation by a non-peptide agonist which interacts with specific receptors (ATP-y-S for purigenic receptors) and c) the Ca++ mediated direct activation of phospholipase A2 (ionomycin).
The results show that depending on the agonist used, the secretion of the metabolites produced as a results of the stimulation is vectorial in nature. Furthermore, the direction of polarization (whether release is directed to the apical or basolateral wells) is agonist specific. Thus, with bradykinin, ATP-y-S, and ionomycin, the release of liberated AA is predominantly to the basolateral side of the cells. The eicosanoids synthesized (with trypsin and thrombin) are also secreted by the cells in a clearly vectorial manner, but this secretion of PGs is directed to the apical well. Collectively, the data show a) the vectorial nature of release of AA and its metabolites in MDCK epithelial cells, and b) agonist specificity for the direction of the vector. It should be noted, however, that the present studies using cells radiolabeled with arachidonic acid do not measure arachidonate mass released and may favor a rapidly turnover pool of arachidonate which may be sequestered to specific membrane domains.
Another interesting feature of the stimulus coupling process revealed by this study is the "sidedness" of epithelial cells. In the case of bradykinin, ATP-y-S, and ionomycin, the extent of activation, measured as AA release, is clearly dependent on the side to which the agonist was added, The "sidedness" is best illustrated by the results of the experiments with ionomycin.
Ten fold higher concentration of ionomycin was required to elicit the same response when applied from the basolateral side of the cells as compared to the addition of this reagent to the apical well.
The measured ED56 of the agonists were all of the same order of magnitude. Thus, it appears that the affinity of the receptors are not measurably different regardless of the side on which they are present. Therefore, the large differences in responses observed may be attributed to the numbers of limiting critical molecules present on either side of the cells. Whatever is the explanation, the responses observed appears to be clearly domain specific with a given agonist.
The data given in this report suggest structural differences between membrane domains, which in turn confer functional differences leading to specific secretory patterns of metabolites. Published literature on MDCK cells presents convincing evidence for epithelial sorting of membrane components and a barrier to diffusion of proteins and lipids, as long as the tight junctions remain intact in these cells (1, 3, 5) . These characteristics of MDCK cells provide adequate explanation for the observed pattern of secretion of AA and PGs reported here. In MDCK cells, phosphatidylcholine has been shown to be predominantly localized in the basolateral membrane (33) . In bradykinin induced phospholipase activation, phosphatidylcholine has been claimed to be the source of the released AA (30) . If this assumption is correct, it follows that the membrane domains enriched with phosphatidylcholine will be the source for the AA deacylated with bradykinin. Since the released AA cannot diffuse uniformly across the tight junctions of the cell, this reaction product will be secreted vectorially from the basolateral side of the cell. Membrane sorting might also result in a functionally optimal but topographically asymmetrical segregation of components of the transductional apparatus (7-15). The receptors, G proteins, and target enzymes, (phospholipases and PG synthase in this case) might also be enriched in a domain specific fashion, due to sorting and transcytosis (8, 10, 11, 13) . The magnitude of the response of the cell to a given stimulus will be limited by the number of the relevant functional molecules segregated on the side to which the agonist is added, or the side with which it is capable of interacting. Thus, the agonist and domain specific responses reported here may be readily explained on the basis of epithelial polarity, arising from membrane sorting. Do the observations reported here have any relevance in the physiological context of AA metabolism? If epithelial polarity exists in vivo it is not unreasonable to expect some physiologic significance for the observations reported here. Previous studies with endothelial cells and smooth muscle cells in co-culture demonstrated polarity to arachidonic acid metabolism and suggested that prostaglandin production by smooth muscle cells could occur in response to stimuli that caused arachidonic acid release from endothelial cells (18, 19) . Stimulated platelets can provide arachidonate for metabolism by leukocyte lipoxygenases (20) and endo-peroxide substrates for vascular prostacyclin synthesis (21). Exchange of hydro-peroxy and hydroxy acids between platelets and neutrophils can lead to formation of new bioactive metabolites (22). Metabolism of neutrophil derived leukotriene A4 by erythrocytes (24), platelets (34) and mast cells (35) have been reported. When taken together with findings in the literature documenting transcellular metabolism of AA derived products, the following possibility does not appear to be an unreasonable one to suggest.
With close intercellular contact, as happens in platelet adhesion to vascular endothelium, the polarized release of metabolites such as reported here may be the most effective way to deliver substrates for the transcellular metabolism of AA derived compounds. Thus, optimal utilization of platelet derived endo-peroxide for prostacyclin synthesis, or the elaboration of a 
